Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Sector Analysis
UpdatedSep 15, 2025
DataAggregated Company Financials
Companies468
- 7D-0.6%
- 3M14.6%
- 1Y46.2%
- YTD27.2%
Last week, the Healthcare industry hasn't moved much but Shanghai United Imaging Healthcare is up 5.9% in that time. The past year has been better, since the industry has gained 46% in that time. Earnings are forecast to grow by 28% annually.
Sector Valuation and Performance
Has the Chinese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Sep 2025 | CN¥7.0t | CN¥2.2t | CN¥142.2b | 41.3x | 49.2x | 3.2x |
| Wed, 13 Aug 2025 | CN¥6.8t | CN¥2.2t | CN¥152.8b | 40.9x | 44.3x | 3.1x |
| Fri, 11 Jul 2025 | CN¥6.1t | CN¥2.2t | CN¥150.0b | 36.8x | 40.7x | 2.8x |
| Sun, 08 Jun 2025 | CN¥6.0t | CN¥2.2t | CN¥150.2b | 36x | 40.1x | 2.7x |
| Tue, 06 May 2025 | CN¥5.6t | CN¥2.2t | CN¥149.7b | 32.5x | 37.2x | 2.5x |
| Thu, 03 Apr 2025 | CN¥5.8t | CN¥2.2t | CN¥159.1b | 33.4x | 36.7x | 2.6x |
| Sat, 01 Mar 2025 | CN¥5.6t | CN¥2.2t | CN¥153.8b | 31.5x | 36.6x | 2.5x |
| Mon, 27 Jan 2025 | CN¥5.4t | CN¥2.2t | CN¥153.8b | 30.7x | 34.9x | 2.4x |
| Wed, 25 Dec 2024 | CN¥5.7t | CN¥2.2t | CN¥153.7b | 32.6x | 37.3x | 2.6x |
| Fri, 22 Nov 2024 | CN¥6.0t | CN¥2.2t | CN¥154.1b | 34.5x | 38.9x | 2.7x |
| Sun, 20 Oct 2024 | CN¥5.7t | CN¥2.2t | CN¥162.0b | 32.2x | 35.5x | 2.6x |
| Tue, 17 Sep 2024 | CN¥4.8t | CN¥2.2t | CN¥161.9b | 27.1x | 29.4x | 2.1x |
| Thu, 15 Aug 2024 | CN¥5.1t | CN¥2.3t | CN¥166.3b | 28x | 30.6x | 2.2x |
| Sat, 13 Jul 2024 | CN¥5.1t | CN¥2.3t | CN¥167.0b | 28.1x | 30.8x | 2.3x |
| Mon, 10 Jun 2024 | CN¥5.5t | CN¥2.3t | CN¥164.9b | 29.7x | 33.5x | 2.4x |
| Wed, 08 May 2024 | CN¥6.1t | CN¥2.3t | CN¥167.6b | 33.8x | 36.5x | 2.7x |
| Fri, 05 Apr 2024 | CN¥5.8t | CN¥2.3t | CN¥172.9b | 30.7x | 33.5x | 2.5x |
| Sun, 03 Mar 2024 | CN¥5.9t | CN¥2.3t | CN¥179.0b | 29.8x | 33x | 2.6x |
| Tue, 30 Jan 2024 | CN¥5.7t | CN¥2.3t | CN¥176.9b | 29.4x | 32.1x | 2.5x |
| Thu, 28 Dec 2023 | CN¥6.4t | CN¥2.3t | CN¥177.1b | 34.3x | 36x | 2.8x |
| Sat, 25 Nov 2023 | CN¥6.7t | CN¥2.3t | CN¥177.2b | 37x | 38x | 2.9x |
| Mon, 23 Oct 2023 | CN¥6.1t | CN¥2.3t | CN¥185.2b | 31.7x | 33.1x | 2.7x |
| Wed, 20 Sep 2023 | CN¥6.3t | CN¥2.3t | CN¥185.2b | 32.2x | 34.3x | 2.8x |
| Fri, 18 Aug 2023 | CN¥6.4t | CN¥2.3t | CN¥193.3b | 32.5x | 32.9x | 2.8x |
| Sun, 16 Jul 2023 | CN¥6.5t | CN¥2.3t | CN¥192.9b | 33.1x | 33.9x | 2.9x |
| Tue, 13 Jun 2023 | CN¥6.7t | CN¥2.3t | CN¥191.7b | 34.5x | 34.8x | 2.9x |
| Thu, 11 May 2023 | CN¥6.9t | CN¥2.3t | CN¥192.3b | 35.1x | 35.8x | 3x |
| Sat, 08 Apr 2023 | CN¥7.3t | CN¥2.2t | CN¥235.6b | 37.3x | 30.8x | 3.2x |
| Mon, 06 Mar 2023 | CN¥7.2t | CN¥2.2t | CN¥229.6b | 38.6x | 31.4x | 3.3x |
| Wed, 01 Feb 2023 | CN¥7.3t | CN¥2.2t | CN¥233.4b | 37.7x | 31.2x | 3.3x |
| Fri, 30 Dec 2022 | CN¥6.9t | CN¥2.2t | CN¥232.2b | 35.5x | 29.6x | 3.1x |
| Sun, 27 Nov 2022 | CN¥6.9t | CN¥2.2t | CN¥231.8b | 37.4x | 29.8x | 3.1x |
| Tue, 25 Oct 2022 | CN¥6.7t | CN¥2.1t | CN¥229.9b | 35.9x | 29.3x | 3.2x |
| Thu, 22 Sep 2022 | CN¥6.0t | CN¥2.1t | CN¥223.6b | 30.7x | 26.8x | 2.9x |
Price to Earnings Ratio
26.8x
Current Industry PE
- Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 49.2x which is higher than its 3-year average PE of 34.5x.
- The 3-year average PS ratio of 2.8x is lower than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare sector?
| CN Market | 2.24% | |
| Healthcare | -0.55% | |
| Medical Equipment | 1.96% | |
| Healthcare Services | 1.16% | |
| Healthtech | 0.64% | |
| Life Sciences | 0.41% | |
| Biotech | -0.90% | |
| Pharma | -1.92% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 58.4x.
- Analysts are expecting annual earnings growth of 55.1%, which is higher than its past year's earnings decline of 17.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 74% over the next 5 years.
- This is better than its past earnings growth rate of 37% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 20% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300759 Pharmaron Beijing | CN¥35.90 | 10.1% +CN¥5.8b | 72.7% | PE46x | |
| 603127 Joinn Laboratories(China)Co.Ltd | CN¥41.65 | 20.2% +CN¥5.1b | 208.5% | PE100.2x | |
| 300049 Inner Mongolia Furui Medical Science | CN¥82.24 | 28.7% +CN¥4.9b | 125.3% | PE242.5x | |
| 603301 Zhende Medical | CN¥38.10 | 41.1% +CN¥3.0b | 86.4% | PE28.8x | |
| 000766 Tonghua Golden-Horse Pharmaceutical Industry CoLtd | CN¥27.14 | 11.7% +CN¥2.8b | 100.0% | PE431.6x |